# Project CADENCE (CAncer Detected Early caN be CurEd)

> **NCT05633342** · — · UNKNOWN · sponsor: **MiRXES Pte Ltd** · enrollment: 15000 (estimated)

## Conditions studied

- Thoracic Cancer
- Ovarian Cancer
- Liver Cancer
- Prostate Cancer
- Gastric Cancer
- Colorectal Cancer
- Breast Cancer
- Esophageal Cancer
- Pancreatic Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05633342
- **Lead sponsor:** MiRXES Pte Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-07-07
- **Primary completion:** 2024-12
- **Final completion:** 2025-05
- **Target enrollment:** 15000 (ESTIMATED)
- **Last updated:** 2023-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05633342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05633342, "Project CADENCE (CAncer Detected Early caN be CurEd)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05633342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*